Shanghai Haoyuan Chemexpress Co., Ltd. (SHA:688131)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2016	FY 2015
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2016	Dec 31, 2015
Molecular Building Blocks, Tool Compounds and Biochemical Reagents				235.68M	150.64M
Molecular Building Blocks, Tool Compounds and Biochemical Reagents Growth				56.46%	-
Active Pharmaceutical Ingredient, Intermediate and Preparations				167.25M	148.19M
Active Pharmaceutical Ingredient, Intermediate and Preparations Growth				12.86%	-
Total				402.93M	298.83M
Total Growth				34.84%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2016	FY 2015
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2016	Dec 31, 2015
China				235.89M	175.11M
China Growth				34.72%	-
Overseas				167.04M	123.73M
Overseas Growth				35.01%	-
Total				402.93M	298.83M
Total Growth				34.84%	-

Source: S&P Global Market Intelligence.